Acyclolaxaphycin B
| Internal ID | d7070053-828e-44b6-93f8-e01fcc1de822 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | (2R,3S)-2-[[(2S)-2-[[(3R)-3-[[(2S,3R)-2-[[(2R)-2-[[(2S)-1-[(2S,3R)-2-[[(2R,3R)-4-amino-2-[[(2S,3S)-2-[[(2S)-5-amino-2-[[(2R,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-hydroxy-4-methylpentanoyl]amino]-5-oxopentanoyl]-methylamino]-3-methylpentanoyl]amino]-3-hydroxy-4-oxobutanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]decanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxy-4-methylpentanoic acid |
| SMILES (Canonical) | CCCCCCCC(CC(=O)NC(C(C)C)C(=O)NC(C(C(C)C)O)C(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(C(C(=O)N)O)NC(=O)C(C(C)CC)N(C)C(=O)C(CCC(=O)N)NC(=O)C(C(C(C)C)O)NC(=O)C(C)N |
| SMILES (Isomeric) | CCCCCCC[C@H](CC(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C(C)C)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]([C@H](C(=O)N)O)NC(=O)[C@H]([C@@H](C)CC)N(C)C(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]([C@H](C(C)C)O)NC(=O)[C@H](C)N |
| InChI | InChI=1S/C65H116N14O20/c1-16-18-19-20-21-23-38(29-43(83)72-44(31(5)6)58(91)77-49(65(98)99)52(85)33(9)10)69-59(92)45(36(13)80)73-56(89)40(28-30(3)4)71-57(90)41-24-22-27-79(41)64(97)46(37(14)81)74-61(94)48(53(86)54(68)87)76-62(95)50(34(11)17-2)78(15)63(96)39(25-26-42(67)82)70-60(93)47(51(84)32(7)8)75-55(88)35(12)66/h30-41,44-53,80-81,84-86H,16-29,66H2,1-15H3,(H2,67,82)(H2,68,87)(H,69,92)(H,70,93)(H,71,90)(H,72,83)(H,73,89)(H,74,94)(H,75,88)(H,76,95)(H,77,91)(H,98,99)/t34-,35-,36+,37+,38+,39-,40+,41-,44-,45-,46-,47+,48+,49+,50-,51-,52-,53+/m0/s1 |
| InChI Key | ARBTXEGGGLHUPG-FYHKVEBYSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C65H116N14O20 |
| Molecular Weight | 1413.70 g/mol |
| Exact Mass | 1412.84903214 g/mol |
| Topological Polar Surface Area (TPSA) | 553.00 Ų |
| XlogP | -2.50 |
| Atomic LogP (AlogP) | -3.99 |
| H-Bond Acceptor | 20 |
| H-Bond Donor | 18 |
| Rotatable Bonds | 45 |
| RefChem:109614 |
| (2R,3S)-2-(((2S)-2-(((3R)-3-(((2S,3R)-2-(((2R)-2-(((2S)-1-((2S,3R)-2-(((2R,3R)-4-amino-2-(((2S,3S)-2-(((2S)-5-amino-2-(((2R,3S)-2-(((2S)-2-aminopropanoyl)amino)-3-hydroxy-4-methylpentanoyl)amino)-5-oxopentanoyl)-methylamino)-3-methylpentanoyl)amino)-3-hydroxy-4-oxobutanoyl)amino)-3-hydroxybutanoyl)pyrrolidine-2-carbonyl)amino)-4-methylpentanoyl)amino)-3-hydroxybutanoyl)amino)decanoyl)amino)-3-methylbutanoyl)amino)-3-hydroxy-4-methylpentanoic acid |
| (2R,3S)-2-((S)-2-((R)-3-((2S,3R)-2-((R)-2-((S)-1-(((2R,3R)-4-amino-2-((2S,3S)-2-((S)-5-amino-2-((2R,3S)-2-((S)-2-aminopropanamido)-3-hydroxy-4-methylpentanamido)-N-methyl-5-oxopentanamido)-3-methylpentanamido)-3-hydroxy-4-oxobutanoyl)-L-threonyl)pyrrolidine-2-carboxamido)-4-methylpentanamido)-3-hydroxybutanamido)decanamido)-3-methylbutanamido)-3-hydroxy-4-methylpentanoic acid |
| (2R,3S)-2-[[(2S)-2-[[(3R)-3-[[(2S,3R)-2-[[(2R)-2-[[(2S)-1-[(2S,3R)-2-[[(2R,3R)-4-amino-2-[[(2S,3S)-2-[[(2S)-5-amino-2-[[(2R,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-hydroxy-4-methylpentanoyl]amino]-5-oxopentanoyl]-methylamino]-3-methylpentanoyl]amino]-3-hydroxy-4-oxobutanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]decanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxy-4-methylpentanoic acid |
| CHEBI:227771 |
| DTXSID001046530 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.6363 | 63.63% |
| Caco-2 | - | 0.8610 | 86.10% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Mitochondria | 0.5171 | 51.71% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8270 | 82.70% |
| OATP1B3 inhibitior | + | 0.9017 | 90.17% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9292 | 92.92% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.8495 | 84.95% |
| CYP3A4 substrate | + | 0.7463 | 74.63% |
| CYP2C9 substrate | - | 0.8002 | 80.02% |
| CYP2D6 substrate | - | 0.8151 | 81.51% |
| CYP3A4 inhibition | - | 0.8617 | 86.17% |
| CYP2C9 inhibition | - | 0.8889 | 88.89% |
| CYP2C19 inhibition | - | 0.8705 | 87.05% |
| CYP2D6 inhibition | - | 0.9344 | 93.44% |
| CYP1A2 inhibition | - | 0.8978 | 89.78% |
| CYP2C8 inhibition | + | 0.7015 | 70.15% |
| CYP inhibitory promiscuity | - | 0.9832 | 98.32% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.6427 | 64.27% |
| Eye corrosion | - | 0.9858 | 98.58% |
| Eye irritation | - | 0.8957 | 89.57% |
| Skin irritation | - | 0.7977 | 79.77% |
| Skin corrosion | - | 0.9161 | 91.61% |
| Ames mutagenesis | - | 0.7500 | 75.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6807 | 68.07% |
| Micronuclear | + | 0.7500 | 75.00% |
| Hepatotoxicity | + | 0.5409 | 54.09% |
| skin sensitisation | - | 0.8839 | 88.39% |
| Respiratory toxicity | + | 0.7000 | 70.00% |
| Reproductive toxicity | + | 0.7667 | 76.67% |
| Mitochondrial toxicity | + | 0.6875 | 68.75% |
| Nephrotoxicity | - | 0.7197 | 71.97% |
| Acute Oral Toxicity (c) | III | 0.6688 | 66.88% |
| Estrogen receptor binding | + | 0.6404 | 64.04% |
| Androgen receptor binding | + | 0.7138 | 71.38% |
| Thyroid receptor binding | + | 0.6416 | 64.16% |
| Glucocorticoid receptor binding | + | 0.7411 | 74.11% |
| Aromatase binding | + | 0.7610 | 76.10% |
| PPAR gamma | + | 0.7952 | 79.52% |
| Honey bee toxicity | - | 0.7448 | 74.48% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | + | 0.5189 | 51.89% |
| Fish aquatic toxicity | + | 0.6471 | 64.71% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3837 | P07711 | Cathepsin L | 99.96% | 96.61% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.88% | 98.95% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 99.43% | 98.10% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 99.16% | 100.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.16% | 98.33% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 98.71% | 93.56% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 98.47% | 95.17% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.46% | 98.94% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 98.36% | 91.81% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.29% | 96.09% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 98.25% | 90.17% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 98.08% | 94.45% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 97.78% | 96.67% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 97.49% | 92.38% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 96.81% | 97.50% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 96.77% | 96.47% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 96.72% | 99.77% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.64% | 99.17% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 96.42% | 93.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 95.62% | 100.00% |
| CHEMBL4801 | P29466 | Caspase-1 | 95.59% | 96.85% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 95.46% | 98.24% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 95.43% | 95.52% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 95.42% | 97.43% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.56% | 91.19% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 94.55% | 89.63% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 94.14% | 100.00% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 94.13% | 93.10% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 94.10% | 97.64% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 94.09% | 100.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.91% | 97.09% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 93.67% | 92.86% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 93.38% | 98.89% |
| CHEMBL3468 | P55210 | Caspase-7 | 93.08% | 95.68% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 92.62% | 94.66% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 92.49% | 97.21% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 92.34% | 97.29% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 92.02% | 97.86% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 91.52% | 96.95% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 91.48% | 88.42% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.45% | 90.71% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 91.14% | 95.00% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 90.92% | 98.77% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 90.90% | 97.29% |
| CHEMBL3776 | Q14790 | Caspase-8 | 90.81% | 97.06% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 90.56% | 96.67% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 90.54% | 90.08% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 90.47% | 96.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 90.16% | 99.35% |
| CHEMBL238 | Q01959 | Dopamine transporter | 90.11% | 95.88% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 88.21% | 97.50% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.59% | 94.33% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 87.48% | 90.65% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 87.10% | 96.25% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 86.85% | 95.50% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 86.82% | 96.03% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 86.51% | 98.05% |
| CHEMBL3629 | P68400 | Casein kinase II alpha | 85.86% | 98.89% |
| CHEMBL3492 | P49721 | Proteasome Macropain subunit | 85.49% | 90.24% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 85.42% | 96.00% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 85.29% | 90.20% |
| CHEMBL5500 | Q92831 | Histone acetyltransferase PCAF | 85.00% | 91.96% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 84.60% | 83.14% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 84.48% | 82.38% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 84.24% | 97.14% |
| CHEMBL1991 | O14920 | Inhibitor of nuclear factor kappa B kinase beta subunit | 84.06% | 97.15% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 83.80% | 95.89% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.50% | 95.89% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 83.32% | 97.25% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 83.25% | 92.32% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.21% | 96.90% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 83.13% | 98.33% |
| CHEMBL3691 | Q13822 | Autotaxin | 82.10% | 96.39% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 81.88% | 97.64% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 81.81% | 95.36% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 81.75% | 93.33% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 81.29% | 90.24% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 81.16% | 96.37% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 81.04% | 97.47% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 80.84% | 96.11% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 80.41% | 98.03% |
| CHEMBL4071 | P08311 | Cathepsin G | 80.27% | 94.64% |
| CHEMBL4198 | P98170 | Inhibitor of apoptosis protein 3 | 80.23% | 97.79% |
| CHEMBL228 | P31645 | Serotonin transporter | 80.19% | 95.51% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 155801635 |
| LOTUS | LTS0169715 |
| wikiData | Q104203043 |